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Background: Complete hydatiform mole and coexistent viable fetus is very rare. The use of a cervical cerclage for
cervical indications in the presence of this condition has never been reported. Although the diagnosis was made
postnatal, the objective is to present a case with good neonatal outcome.
Case presentation: A patient presented with vaginal spotting around 23 weeks. She has a history of four preterm
deliveries. Her cervix was dilated and a cerclage was placed. She presented again with PPROM around 25 weeks.
She went into spontaneous preterm labor and delivered a viable fetus that is a healthy girl today. Eventually the
pathology of the placenta showed a complete hydatidiform mole.
Conclusion: It is necessary to inform patients about the potential risks and poor outcomes of this condition. For
those who desire all potential interventions, cerclage placement could be considered.
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A twin pregnancy with a complete hydatidiform mole and
a coexistent fetus (CHCF) occurs in approximately 1 in
22,000 to 100,000 pregnancies [1,2]. The probability of
carrying a CHCF to term is low due to the risks of spon-
taneous abortion, preterm delivery, hyperthyroidism,
preeclampsia, vaginal bleeding, thrombolytic disease, and
persistent gestational trophoblastic neoplasia [3]. Early
termination of pregnancy has often been advised in the
past. The course of management of this unusual twin
pregnancy still remains unclear.
Prematurity is clearly a potential risk associated with
CHCF. Despite previously published data that demon-
strated the inefficacy of cervical cerclage, it still remains
as one of the potential alternatives that can be used to de-
crease prematurity associated with cervical variables [4].
The use of cervical cerclage in a patient with presence
of complete hydatidiform mole and a coexistent viable
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The patient was a 27-year-old gravida 7 para 4 who pre-
sented with vaginal spotting at 23 weeks and 2 days of
gestation. Her obstetric history included 4 preterm deliv-
eries and 1 spontaneous abortion at 16 weeks. Her cer-
vix was 4–5 cm dilated with a bulging bag. Ultrasound
showed a live pregnancy with breech presentation, as
well as a placental mass with differential diagnosis of a
chorioangioma measuring 10x40 mm. Cervical length
was unable to be accurately measured secondary to the
anatomical changes. The patient was counseled and she
consented to undergo amniocentesis and rescue cerclage
placement. The amniocentesis showed a karyotype of
46XX. A cerclage was placed using the McDonald tech-
nique. The patient also received betamethasone for fetal
lung maturity secondary to the risks for preterm deliv-
ery. The patient was discharged in stable condition after
2 days. Tocolytics or progesterone was not used.
She returned with vaginal bleeding and premature rup-
ture of the membranes at 25 weeks and 2 days. The po-
tential benefit of retaining the cerclage in order to
prolong latency and decrease complications related to
prematurity was considered. The decision was made
to remove the cerclage at 25 weeks and 6 days due totd. This is an Open Access article distributed under the terms of the Creative
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of preterm labor. She went into spontaneous preterm
labor and vaginal delivery of a viable female fetus
weighting 625 grams. The delivery was uneventful; how-
ever, the placenta was partially retained after delivery.
An exploration of the uterine cavity and cervix was per-
formed. This was followed by curettage due to continued
heavy bleeding. Grape-like structures were seen during
the procedure.
The placenta weighted 200 grams. The tissue appeared
to have two distinct areas, one with normal placental tis-
sue and one mixed with vesicles. This vesicular placental
tissue was reported by pathology to represent gestational
trophoblastic disease. Today, the fetus discussed previ-
ously is a healthy 4-year-old girl without major medical
problems, aside from mild intermittent asthma. Her
mother had a beta-hCG level less than 5 mIU/ml at 8
weeks post partum and is full remission today.
Conclusions
A dilemma in the management of CHCF is whether to
follow them expectantly or to terminate the pregnancy.
With a partial mole and coexisting live fetus, there is a
high chance of fetal malformation and growth restriction
because of associated triploidy [5]. Also, patients need to
be counseled about all possible risks associated with
CHCF, including the potential evolution to a gestational
trophoblastic neoplasia [6]. The incidence of CHCF is
increasing with in vitro fertilization, ovulation stimula-
tion, and other fertility procedures [7]. In this unique
case, the diagnosis of CHCF was made following deliv-
ery. Although cytogenetic studied were not performed,
the karyotype was 46XX with a histology report support-
ing CHCF. However, in most situations, CHCF will be
diagnosed after delivery as diagnosis can be reached only
by invasive methods [8]. We should consider the possi-
bility of CHCF in patients with vaginal bleeding and an
ultrasound abnormality suggestive of a placental mass. If
there is a strong suspicion of CHCF, an amniocentesis
should be performed to rule out triploidy associated with
a partial hydatidiform mole.
In conclusion, a detailed explanation and discussion
about the risks and poor outcomes should be provided to
the patient. Informed consent for interventions that may
prolong the pregnancy should be obtained. A patient
who desires to continue with the pregnancy needs close
surveillance for early detection of maternal complications.
The patient should be followed with ultrasonography
and beta-hCG level measurements [7]. Pertinent tests to
rule out hyperthyroidism, pre-eclampsia, thrombolytic
disease, as well as cervical length should be considered.
Furthermore, regardless of the obstetrical risk associated
with CHCF, our recommendation is to be prepared for
possible procedures, such as a rescue cerclage for cervicalindications. Our patient had a questionable history of cer-
vical insufficiency, and advanced cervical dilation. Rescue
cerclage was performed and the pregnancy continued
until viability was reached. This unique pregnancy
resulted in a healthy mother and child.
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